We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$468M
AUM Growth
+$160M
Cap. Flow
+$174M
Cap. Flow %
37.12%
Top 10 Hldgs %
25.86%
Holding
170
New
51
Increased
61
Reduced
22
Closed
28

Top Sells

Rank Stock Value
1
DLTR icon
Dollar Tree
DLTR
+$5M
2
CIVI
Civitas Resources
CIVI
+$4.58M
3
BABA icon
Alibaba
BABA
+$4.31M
4
CNC icon
Centene
CNC
+$4.16M
5
PRU icon
Prudential Financial
PRU
+$3.94M

Sector Composition

Rank Sector Weight
1 Technology 14.78%
2 Consumer Discretionary 12.04%
3 Healthcare 11.59%
4 Financials 10.04%
5 Materials 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABM icon
76
ABM Industries
ABM
$2.82B
$1.85M 0.4%
+45,277
New +$2.04M
CVEO icon
77
Civeo
CVEO
$322M
$1.83M 0.39%
95,721
+1,908
+2% +$40.8K
BDC icon
78
Belden
BDC
$5.23B
$1.8M 0.38%
27,383
-37,241
-58% -$2.34M
DAN icon
79
Dana Inc
DAN
$3.2B
$1.78M 0.38%
+78,189
New +$1.81M
MTUS icon
80
Metallus
MTUS
$902M
$1.75M 0.37%
106,264
-75,893
-42% -$1.11M
NTUS
81
DELISTED
Natus Medical Inc
NTUS
$1.69M 0.36%
+71,033
New +$1.75M
MAPS
82
DELISTED
WM TECHNOLOGY INC A
MAPS
$1.64M 0.35%
+273,641
New +$2.68M
CHKP icon
83
Check Point Software Technologies
CHKP
$13.3B
$1.63M 0.35%
+13,987
New +$1.62M
OC icon
84
Owens Corning
OC
$12.2B
$1.6M 0.34%
+17,652
New +$1.6M
RLGT icon
85
Radiant Logistics
RLGT
$392M
$1.59M 0.34%
218,565
-66,873
-23% -$481K
HURC icon
86
Hurco Companies Inc
HURC
$144M
$1.55M 0.33%
52,115
+1,034
+2% +$33K
VSH icon
87
Vishay Intertechnology
VSH
$5.19B
$1.53M 0.33%
+69,865
New +$1.43M
COCO icon
88
Vita Coco
COCO
$3.67B
$1.49M 0.32%
+133,161
New +$1.69M
SABR icon
89
Sabre
SABR
$823M
$1.49M 0.32%
173,171
+110,610
+177% +$1.06M
CASS icon
90
Cass Information Systems
CASS
$730M
$1.48M 0.32%
37,519
-14,772
-28% -$626K
PLPC icon
91
Preformed Line Products
PLPC
$2.25B
$1.46M 0.31%
22,617
+471
+2% +$30.8K
LEXX icon
92
Lexaria Bioscience
LEXX
$8.87M
$1.45M 0.31%
23,941
+446
+2% +$38.1K
GER
93
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
$1.41M 0.3%
134,543
ULH icon
94
Universal Logistics Holdings
ULH
$516M
$1.38M 0.29%
72,973
+1,462
+2% +$28.9K
TRUE
95
DELISTED
TrueCar
TRUE
$1.37M 0.29%
+404,112
New +$1.54M
PSFE icon
96
Paysafe
PSFE
$361M
$1.37M 0.29%
+29,225
New +$1.95M
LUMN icon
97
Lumen
LUMN
$6.66B
$1.27M 0.27%
101,659
+80,343
+377% +$1.02M
CLF icon
98
Cleveland-Cliffs
CLF
$7.11B
$1.26M 0.27%
+58,103
New +$1.25M
CPS icon
99
Cooper-Standard Automotive
CPS
$525M
$1.24M 0.27%
55,365
+1,042
+2% +$24.5K
NNBR icon
100
NN Inc
NNBR
$306M
$1.24M 0.26%
+301,182
New +$1.47M

Similar funds

Invenomic Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Invenomic Capital Management held 170 positions worth $468M, up 52% from $308M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management deployed $174M of net new capital in Q4 2021, opening 51 new positions and adding to 61 existing holdings. Its largest new stake was AT&T: 626,014 shares worth $11.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 7.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Civitas Resources, an estimated $4.58M trimmed.

  • Invenomic Capital Management's largest Q4 2021 buy was AT&T: 626,014 shares worth $11.6M.
  • Invenomic Capital Management added most to Cigna in Q4 2021, an estimated $5.95M increase.
  • Invenomic Capital Management's biggest Q4 2021 reduction was Civitas Resources, cutting an estimated $4.58M.
  • Invenomic Capital Management fully exited Dollar Tree in Q4 2021, selling an estimated $5M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $468M portfolio in Q4 2021.
  • Invenomic Capital Management opened 51 new positions and closed 28 in Q4 2021.
  • Invenomic Capital Management's portfolio value rose 52% quarter-over-quarter to $468M.

Based on Invenomic Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.